AETHLON MEDICAL, INC. Share-based Payment Arrangement, Expense, after Tax
AETHLON MEDICAL, INC. (AEMD) reported Share-based Payment Arrangement, Expense, after Tax of $175.04 thousand for the 3-month period ending 2012-12-31, per its 10-Q filed 2013-02-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax · last filed 2013-02-12
- AETHLON MEDICAL, INC. share-based payment arrangement, expense, after tax for the quarter ending 2012-12-31 was $175.04K, a 8.43% increase year-over-year.
- AETHLON MEDICAL, INC. share-based payment arrangement, expense, after tax for the quarter ending 2012-09-30 was $226.20K, a 0.97% increase year-over-year.
- AETHLON MEDICAL, INC. share-based payment arrangement, expense, after tax for the quarter ending 2011-12-31 was $161.44K.
- AETHLON MEDICAL, INC. share-based payment arrangement, expense, after tax for the quarter ending 2011-09-30 was $224.03K.
| Period end | Share-based Payment Arrangement, Expense, after Tax 3 month | Share-based Payment Arrangement, Expense, after Tax 6 month | Share-based Payment Arrangement, Expense, after Tax 9 month |
|---|---|---|---|
| 2012-12-31 | $175.04K 10-Q · filed 2013-02-12 | $401.24K derived: sum of 2 quarters · filed 2013-02-12 | $570.54K 10-Q · filed 2013-02-12 |
| 2012-09-30 | $226.20K 10-Q · filed 2012-11-13 | $395.50K 10-Q · filed 2012-11-13 | |
| 2011-12-31 | $161.44K 10-Q · filed 2013-02-12 | $385.47K derived: sum of 2 quarters · filed 2013-02-12 | $609.50K 10-Q · filed 2013-02-12 |
| 2011-09-30 | $224.03K 10-Q · filed 2012-11-13 | $448.06K 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |